Skip to main content

Shiao-Wen David Hsu

Professor of Medicine
Medicine, Medical Oncology
Duke Box 3233, Durham, NC 27710
Dept of Medicine, Box 3233, Durham, NC 27710

Current Appointments & Affiliations


Professor of Medicine · 2024 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 2004 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.

Journal Article Ann Surg Oncol · October 2025 BACKGROUND: Hepatic arterial infusion (HAI) chemotherapy is an expanding treatment for patients with unresectable colorectal liver metastases (uCRLM). This study examined circulating tumor DNA (ctDNA) as a novel biomarker to prognosticate oncologic outcome ... Full text Link to item Cite

Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.

Journal Article Ann Surg Oncol · April 2025 BACKGROUND: Randomized data suggest improved survival with adjuvant chemotherapy for biliary tract cancers; however, subset analyses of intrahepatic cholangiocarcinoma (IHC) show limited survival benefit. This study evaluated the impact of adjuvant chemoth ... Full text Link to item Cite

Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers.

Journal Article Ann Surg Oncol · August 2023 BACKGROUND: Resection remains the cornerstone of curative-intent treatment for biliary tract cancers (BTCs). However, recent randomized data also support a role for adjuvant chemotherapy (AC). This study aimed to characterize trends in the use of AC and su ... Full text Link to item Cite
View All Publications

Recent Grants


Role of the NLRP3-NLRC5 Signaling Pathway in Melanoma Immune Evasion and Dormancy

ResearchCollaborator · Awarded by Department of Defense · 2024 - 2027

Precision Medicine Trial Using MicroOrganoSpheres to Guide Care in Colorectal Cancer

Clinical TrialPrincipal Investigator · Awarded by Mario Family Foundation · 2022 - 2025

View All Grants

Education, Training & Certifications


University of North Carolina, Chapel Hill · 2001 M.D.